| Dr Natalia Cardona, DPM | |
|
6080 W Boynton Beach Blvd Ste 100, Boynton Beach, FL 33437-3586 | |
| (561) 328-8066 | |
| Not Available |
| Full Name | Dr Natalia Cardona |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 8 Years |
| Location | 6080 W Boynton Beach Blvd Ste 100, Boynton Beach, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871943407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO4058 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Daryl Gershbein Dpm Pa | 1557457769 | 6 |
News Archive
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.
A group of genes whose expression is significantly altered following exposure to drug paraphernalia after an enforced 'cold-turkey' period have been identified. Researchers writing in the open access journal BMC Neuroscience studied gene expression in the brains of heroin-addicted rats, identifying those genes that may be involved in precipitating a relapse.
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure.
› Verified 3 days ago
| Provider Name | Adam J Katz Dpm Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467676429 PECOS PAC ID: 1557323482 Enrollment ID: O20041102000795 |
News Archive
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.
A group of genes whose expression is significantly altered following exposure to drug paraphernalia after an enforced 'cold-turkey' period have been identified. Researchers writing in the open access journal BMC Neuroscience studied gene expression in the brains of heroin-addicted rats, identifying those genes that may be involved in precipitating a relapse.
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure.
› Verified 3 days ago
| Provider Name | Daryl Gershbein Dpm Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417919291 PECOS PAC ID: 1557457769 Enrollment ID: O20071019000150 |
News Archive
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.
A group of genes whose expression is significantly altered following exposure to drug paraphernalia after an enforced 'cold-turkey' period have been identified. Researchers writing in the open access journal BMC Neuroscience studied gene expression in the brains of heroin-addicted rats, identifying those genes that may be involved in precipitating a relapse.
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure.
› Verified 3 days ago
| Provider Name | The Mas Family Irrevocable Trust Agreement Dated September 3, 2014 |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619277647 PECOS PAC ID: 7315122454 Enrollment ID: O20110504000747 |
News Archive
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.
A group of genes whose expression is significantly altered following exposure to drug paraphernalia after an enforced 'cold-turkey' period have been identified. Researchers writing in the open access journal BMC Neuroscience studied gene expression in the brains of heroin-addicted rats, identifying those genes that may be involved in precipitating a relapse.
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure.
› Verified 3 days ago
| Provider Name | Dedicated Senior Medical Center Of Florida, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1881055366 PECOS PAC ID: 4486932100 Enrollment ID: O20161101001703 |
News Archive
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.
A group of genes whose expression is significantly altered following exposure to drug paraphernalia after an enforced 'cold-turkey' period have been identified. Researchers writing in the open access journal BMC Neuroscience studied gene expression in the brains of heroin-addicted rats, identifying those genes that may be involved in precipitating a relapse.
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure.
› Verified 3 days ago
| Provider Name | Podiatry Health Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1700441342 PECOS PAC ID: 3173856556 Enrollment ID: O20190618001800 |
News Archive
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.
A group of genes whose expression is significantly altered following exposure to drug paraphernalia after an enforced 'cold-turkey' period have been identified. Researchers writing in the open access journal BMC Neuroscience studied gene expression in the brains of heroin-addicted rats, identifying those genes that may be involved in precipitating a relapse.
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Natalia Cardona, DPM 6080 W Boynton Beach Blvd Ste 100, Boynton Beach, FL 33437-3586 Ph: (561) 364-9584 | Dr Natalia Cardona, DPM 6080 W Boynton Beach Blvd Ste 100, Boynton Beach, FL 33437-3586 Ph: (561) 328-8066 |
News Archive
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.
A group of genes whose expression is significantly altered following exposure to drug paraphernalia after an enforced 'cold-turkey' period have been identified. Researchers writing in the open access journal BMC Neuroscience studied gene expression in the brains of heroin-addicted rats, identifying those genes that may be involved in precipitating a relapse.
New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure.
› Verified 3 days ago
Ira Spinner Dpm Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 10075 Jog Rd, Ste 208, Boynton Beach, FL 33437 Phone: 561-734-4867 Fax: 561-736-7433 | |
Mark G Warren Dpm Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1325 S Congress Ave, Suite 108, Boynton Beach, FL 33426 Phone: 561-369-3300 Fax: 561-734-2811 | |
Lyle Sklar, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 112 S Federal Hwy, Suite 1, Boynton Beach, FL 33435 Phone: 561-736-1033 Fax: 561-404-1445 | |
Dr. David Feierman, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 4785 North Congress Ave, Boynton Beach, FL 33426 Phone: 561-439-3338 Fax: 561-439-3403 | |
Susan B Mattison, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3695 W Boynton Beach Blvd, Suite 4, Boynton Beach, FL 33436 Phone: 561-364-5522 | |
Dr. Michael T Kazamias, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 7512 Colony Lake Drive, Boynton Beach, FL 33436 Phone: 561-963-7465 Fax: 561-963-7465 | |
One Stop Foot And Ankle Care Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1880 N Congress Ave Ste 309, Boynton Beach, FL 33426 Phone: 561-778-2100 Fax: 561-778-2118 |